
Jeffrey T. Palenik
Examiner (ID: 8947, Phone: (571)270-1966 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 1192 |
| Issued Applications | 644 |
| Pending Applications | 99 |
| Abandoned Applications | 467 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19297694
[patent_doc_number] => 20240226260
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-07-11
[patent_title] => VACCINE COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF URINARY TRACT INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/277150
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15058
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18277150
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/277150 | Vaccine compositions and methods for the treatment and prevention of urinary tract infections | Feb 15, 2022 | Issued |
Array
(
[id] => 17625672
[patent_doc_number] => 20220160687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => PHARMACEUTICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/671157
[patent_app_country] => US
[patent_app_date] => 2022-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28075
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17671157
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/671157 | Pharmaceutical compositions | Feb 13, 2022 | Issued |
Array
(
[id] => 17712264
[patent_doc_number] => 11376243
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-05
[patent_title] => Pharmaceutical compositions
[patent_app_type] => utility
[patent_app_number] => 17/671207
[patent_app_country] => US
[patent_app_date] => 2022-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 27
[patent_no_of_words] => 28111
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17671207
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/671207 | Pharmaceutical compositions | Feb 13, 2022 | Issued |
Array
(
[id] => 19359363
[patent_doc_number] => 20240261397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => IMMUNE PREPARATION, COMPOSITION COMPRISING IMMUNE PREPARATION AND USE THEREOF, AND PREPARATION METHOD
[patent_app_type] => utility
[patent_app_number] => 18/284812
[patent_app_country] => US
[patent_app_date] => 2022-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7963
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18284812
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/284812 | IMMUNE PREPARATION, COMPOSITION COMPRISING IMMUNE PREPARATION AND USE THEREOF, AND PREPARATION METHOD | Jan 26, 2022 | Pending |
Array
(
[id] => 19584962
[patent_doc_number] => 20240382519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-21
[patent_title] => MONOVALENT COPPER/PORPHYRIDIUM SP. POLYSACCHARIDE COMPLEXES, RELATED PRODUCTS AND METHODS OF PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/273467
[patent_app_country] => US
[patent_app_date] => 2022-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11363
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18273467
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/273467 | MONOVALENT COPPER/PORPHYRIDIUM SP. POLYSACCHARIDE COMPLEXES, RELATED PRODUCTS AND METHODS OF PREPARATION THEREOF | Jan 3, 2022 | Abandoned |
Array
(
[id] => 19001985
[patent_doc_number] => 20240066056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => Formulations of a Prophylactic Nasal Spray and Methods of Use and Manufacture Thereof
[patent_app_type] => utility
[patent_app_number] => 18/260222
[patent_app_country] => US
[patent_app_date] => 2022-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3784
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18260222
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/260222 | Formulations of a Prophylactic Nasal Spray and Methods of Use and Manufacture Thereof | Jan 2, 2022 | Pending |
Array
(
[id] => 18953766
[patent_doc_number] => 20240042093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => IN SITU SOLIDIFYING INJECTABLE COMPOSITIONS WITH TRANSIENT CONTRAST AGENTS AND METHODS OF MAKING AND USING THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/268786
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22909
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -70
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18268786
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/268786 | IN SITU SOLIDIFYING INJECTABLE COMPOSITIONS WITH TRANSIENT CONTRAST AGENTS AND METHODS OF MAKING AND USING THEREOF | Dec 21, 2021 | Pending |
Array
(
[id] => 19119990
[patent_doc_number] => 11963951
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Pharmaceutical compositions
[patent_app_type] => utility
[patent_app_number] => 17/552768
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 27
[patent_no_of_words] => 28084
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552768
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/552768 | Pharmaceutical compositions | Dec 15, 2021 | Issued |
Array
(
[id] => 19032317
[patent_doc_number] => 20240082132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => STABILIZATION OF THIOPYRIDINONE COMPOUND AND YELLOWING REDUCTION OF COMPOSITION COMPRISING SAME
[patent_app_type] => utility
[patent_app_number] => 18/267333
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12251
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18267333
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/267333 | STABILIZATION OF THIOPYRIDINONE COMPOUND AND YELLOWING REDUCTION OF COMPOSITION COMPRISING SAME | Dec 9, 2021 | Pending |
Array
(
[id] => 18921224
[patent_doc_number] => 20240024228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => Apremilast Ophthalmic Compositions
[patent_app_type] => utility
[patent_app_number] => 18/256733
[patent_app_country] => US
[patent_app_date] => 2021-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6105
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18256733
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/256733 | Apremilast Ophthalmic Compositions | Dec 7, 2021 | Pending |
Array
(
[id] => 18806749
[patent_doc_number] => 20230381080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => USE OF PARTICULAR AMINO ACIDS AS A PRETREATMENT FOR A PROCESS FOR DYEING OR BLEACHING KERATIN FIBRES
[patent_app_type] => utility
[patent_app_number] => 18/265749
[patent_app_country] => US
[patent_app_date] => 2021-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12001
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265749
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/265749 | USE OF PARTICULAR AMINO ACIDS AS A PRETREATMENT FOR A PROCESS FOR DYEING OR BLEACHING KERATIN FIBRES | Dec 2, 2021 | Pending |
Array
(
[id] => 18738059
[patent_doc_number] => 20230346971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => METHOD FOR TREATING TUMOURS BY CAPTURING COPPER AND/OR IRON
[patent_app_type] => utility
[patent_app_number] => 18/253694
[patent_app_country] => US
[patent_app_date] => 2021-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12791
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18253694
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/253694 | METHOD FOR TREATING TUMOURS BY CAPTURING COPPER AND/OR IRON | Nov 18, 2021 | Pending |
Array
(
[id] => 18893663
[patent_doc_number] => 20240009148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => Cystamine Formulations and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 18/252873
[patent_app_country] => US
[patent_app_date] => 2021-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5305
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18252873
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/252873 | Cystamine Formulations and Uses Thereof | Nov 17, 2021 | Pending |
Array
(
[id] => 17458592
[patent_doc_number] => 20220071896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => NASAL DRUG PRODUCTS AND METHODS OF THEIR USE
[patent_app_type] => utility
[patent_app_number] => 17/528877
[patent_app_country] => US
[patent_app_date] => 2021-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29752
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17528877
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/528877 | NASAL DRUG PRODUCTS AND METHODS OF THEIR USE | Nov 16, 2021 | Abandoned |
Array
(
[id] => 20848731
[patent_doc_number] => 12685748
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-07-21
[patent_title] => Nanozyme compositions and methods of treatment
[patent_app_type] => utility
[patent_app_number] => 18/037271
[patent_app_country] => US
[patent_app_date] => 2021-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 51
[patent_no_of_words] => 6540
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18037271
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/037271 | NANOZYME COMPOSITIONS AND METHODS OF TREATMENT | Nov 15, 2021 | Issued |
Array
(
[id] => 18986270
[patent_doc_number] => 20240058239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => FRAGRANCE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/255931
[patent_app_country] => US
[patent_app_date] => 2021-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8284
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18255931
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/255931 | FRAGRANCE COMPOSITION | Nov 11, 2021 | Issued |
Array
(
[id] => 18877460
[patent_doc_number] => 20240000829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => COPOLYMER CONTAINING POLY(ETHYLENE GLYCOL) AND POLY(L-AMINO ACID DERIVATIVE), MICROPARTICLES THEREOF AND USE THEREOF IN PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/250121
[patent_app_country] => US
[patent_app_date] => 2021-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11254
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18250121
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/250121 | COPOLYMER CONTAINING POLY(ETHYLENE GLYCOL) AND POLY(L-AMINO ACID DERIVATIVE), MICROPARTICLES THEREOF AND USE THEREOF IN PHARMACEUTICAL COMPOSITION | Nov 8, 2021 | Pending |
Array
(
[id] => 18842521
[patent_doc_number] => 20230404925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => JAK INHIBITORS HAVING A SPECIFIC PARTICLE SIZE DISTRIBUTION
[patent_app_type] => utility
[patent_app_number] => 18/249869
[patent_app_country] => US
[patent_app_date] => 2021-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11501
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18249869
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/249869 | JAK INHIBITORS HAVING A SPECIFIC PARTICLE SIZE DISTRIBUTION | Oct 24, 2021 | Pending |
Array
(
[id] => 17383884
[patent_doc_number] => 20220031736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => USE OF ANIONIC CLAY IN PREPARING LEAD-REMOVING MEDICINE
[patent_app_type] => utility
[patent_app_number] => 17/502105
[patent_app_country] => US
[patent_app_date] => 2021-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10642
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17502105
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/502105 | USE OF ANIONIC CLAY IN PREPARING LEAD-REMOVING MEDICINE | Oct 14, 2021 | Abandoned |
Array
(
[id] => 20958706
[patent_doc_number] => 12729131
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-09-08
[patent_title] => Pigment comprising particles each containing calcium-titanium composite oxide as main component, method for producing same, and use of same
[patent_app_type] => utility
[patent_app_number] => 18/254946
[patent_app_country] => US
[patent_app_date] => 2021-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 10478
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18254946
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/254946 | Pigment Comprising Particles Each Containing Calcium-Titanium Composite Oxide As Main Component, Method For Producing Same, And Use Of Same | Oct 14, 2021 | Pending |